MedPage Today (6/12, George) reports, “The shingles vaccine may be linked with a 20% lower dementia risk,” according to “an analysis of 300,000 health records.” The study revealed that “receiving the herpes zoster vaccine (Zostavax) reduced the probability of a new dementia diagnosis over seven years by 3.5 percentage points,” which “corresponded to a 19.9% relative reduction in dementia risk.” The findings were published online in a “preprint paper on medRxiv, which has not yet been peer reviewed.”
Related Links:
— MedPage Today (requires login and subscription)